middle.news
Island Pharmaceuticals Taps BioCryst Veteran to Boost Galidesivir’s US Biodefence Push
10:00am on Thursday 1st of January, 1970 AEST
•
Healthcare
Read Story
Island Pharmaceuticals Taps BioCryst Veteran to Boost Galidesivir’s US Biodefence Push
10:00am on Thursday 1st of January, 1970 AEST
Key Points
Raymond Taylor brings 40+ years antiviral and biodefence expertise
Direct historical involvement with Galidesivir development
Experience managing over US$490m in US government biodefence funding
Strengthens Island’s FDA Animal Rule pathway execution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE